Novo Nordisk’s CEO, Mike Doustdar, delivered a striking message to the National Press Club today: the chronic disease crisis, driven by obesity, …
For complains, abuse, advertising contact: [email protected]
Tag:
pharmaceuticals
-
-
The Urgent Need for FDA Flexibility in Rare Disease Treatment Washington D.C. – A growing chorus of patient advocates and medical experts …
-
A gripping thriller released in 1993, “The Fugitive” has captivated audiences for decades. But beyond its suspenseful plot and compelling performances, the …
-
Public Opinion Shifts: Trump Receives More Credit for Potential Drug Price Reductions WASHINGTON – The persistent challenge of lowering prescription drug costs …
-
Vertex’s Promising IgA Nephropathy Drug Shows Significant Results in Phase 3 Trial In a significant advancement for the treatment of IgA nephropathy, …
-
Beyond Insulin: How Gene-Modified Cells Could Eradicate Type 1 Diabetes Over 1.2 million Americans live with Type 1 diabetes, a chronic autoimmune …
-
Novo Nordisk Cuts Drug Prices, But Will It Truly Expand Access? Novo Nordisk, a leading pharmaceutical company, announced a significant reduction in …
-
Hims & Hers Navigates Regulatory Scrutiny Amidst GLP-1 Weight Loss Boom The telehealth landscape is undergoing a significant shift as direct-to-consumer companies …
-
The biopharmaceutical landscape is experiencing a shift in leadership, with key appointments signaling strategic directions for companies navigating complex research and development …
-
Over 80% of global COVID-19 vaccine doses administered have been remarkably safe, yet a shadow of concern has lingered over the extremely …